Serial Number | 97820856 |
Word Mark | INOMAX EVOLVE |
Filing Date | Thursday, March 2, 2023 |
Status | 732 - THIRD EXTENSION - GRANTED |
Status Date | Friday, June 27, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 7, 2023 |
Goods and Services | Pharmaceutical preparations, namely, nitric oxide for inhalation for treating pulmonary hypertension and conditions associated with pulmonary hypertension; Pharmaceutical preparations, namely, inhaled pharmaceutical preparations for treating pulmonary hypertension and conditions associated with pulmonary hypertension |
Goods and Services | Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 22, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 22, 2023 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Dublin 15 D15TX2V IE |
Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Dublin 15 D15TX2V IE |
Event Date | Event Description |
Monday, March 6, 2023 | NEW APPLICATION ENTERED |
Wednesday, March 22, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, July 13, 2023 | ASSIGNED TO EXAMINER |
Friday, July 14, 2023 | NON-FINAL ACTION WRITTEN |
Friday, July 14, 2023 | NON-FINAL ACTION E-MAILED |
Friday, July 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, October 2, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, October 2, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, October 4, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, November 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, October 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 7, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, January 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, July 1, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, July 1, 2024 | SOU EXTENSION 1 GRANTED |
Monday, July 1, 2024 | SOU EXTENSION 1 FILED |
Tuesday, December 31, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, December 31, 2024 | SOU EXTENSION 2 FILED |
Wednesday, January 1, 2025 | SOU EXTENSION 2 GRANTED |
Monday, July 1, 2024 | SOU TEAS EXTENSION RECEIVED |
Friday, June 27, 2025 | SOU EXTENSION 3 FILED |
Friday, June 27, 2025 | SOU TEAS EXTENSION RECEIVED |
Friday, June 27, 2025 | SOU EXTENSION 3 GRANTED |
Saturday, June 28, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |